Usually, Fenbendazole is applied to treat parasitic worm diseases in dogs. The beginnings of this anthelmintic medication can be traced back to the start of the 1970s.
Nevertheless, recent studies and case reports published in peer-reviewed articles espouse fenbendazole’s ability to effectively treat some of the most belligerent cancer in humans. Fenbendazole’s ability to treat cancer is thought to be a result of some of the reasons which make fenbendazole different from other existing cancer treatments:
- We stated earlier that a variety of scientific papers published in peer-reviewed journals exist to support and prove the success recorded by Fenbendazole in curing some malignant cancers in humans.
For example, Fenbendazole can singlehandedly cause the recession of cancers in patients suffering huge B-cell lymphoma, renal cell carcinoma, bladder cancer, and metastatic cancer.
- There are a couple of side effects with fenbendazole, it is considered safe for human consumption.
- It is easily acquired over the counter in most countries
- Production is not costly.
If you’ve read the paper “How Fenbendazole Works?” you will be aware that we stated that fenbendazole offers anticancer action which can be compared to the chemotherapies of plant alkaloids that also boasts taxol. Also, it is worth noting that fenbendazole’s unique manner of operation and the remarkable safety profile makes its toxicity levels fall far below what is found amongst traditional chemotherapies.
Several studies and attendant results have shown (by observing emergent patterns) that the onset of some cancers can be linked or traced to parasites, viruses, and such.
Categorically speaking, this may just be the case more times than we know particularly when cancer cells exist in “conducive environments within the victim. A conducive environment is shown by a combination of a feeble immunity and a particular genetic predisposition.
As a result of the above, we completely advocate the application of anti-lactate, anti-worm, anti-parasitic, and other medications for the full treatment of cancer which will also give room for the incorporation of traditional cancer treatments.
Fenbendazole for Human consumption
Unlike Mebendazole which is generally used for human treatment, Fenbendazole is not originally designed for human use. Traditionally, it is applied to animals suffering a case of parasites (like birds, fish, and other mammals). Fenbendazole has been known to handle a variety of parasitic worms like hookworm, whipworms, roundworm, and some tapeworm.
Produced by such brands as Safe-Guard or Panacur, fenbendazole’s ability to treat cancer first came to the attention of the general public several years ago via our published research. But lately, it has generated more interest as a result of the remarkable tale of the man who was able to cure small cell lung cancer fully with Fenbendazole.
Following that victory over cancer, a focused website and Facebook group were birthed to serve as a means to record his experience and that of others who have benefited from the use of Fenbendazole in the treatment of such cancer as melanoma, stage four pancreatic cancer, colorectal cancer, prostate cancer, non-small cell lung cancer, among others.
These aforementioned reports further buttress the existing and increasing scientific proof that shows the potential of several cancer-fighting drugs belonging to the benzimidazole family. As a result of these facts, we believe that fenbendazole shows a considerable cancer-fighting ability just like mebendazole before it.
Some studies have categorically shown that fenbendazole can be more effective in some cases than mebendazole. For example, one of such studies showed that fenbendazole is more effective than mebendazole and some other medications in handling Cryptococcus neoformans which is an unscrupulous fungus that exists everywhere in the world and can result in Cryptococcus meningitis in humans.
Also, amongst the numerous scientific publications that prove Fenbendazole’s cancer-fighting abilities, a particular publication posits that:
The results, in consonance with the earlier data, point to the fact that Fenbendazole is a recent microtubule interfering agent exhibiting anti-neoplastic activity and could be examined as a possible therapeutic agent due to the effect it has on several cellular pathways resulting in the elimination of cancerous cells.
Through their research, the writers of the paper found that the cancer-fighting devices do not only break up the microtubule capacity and proteasomal interference of cancerous cells, rather, it is also able to stop glucose uptake which automatically blocked nutrients from reaching cancer cells. The medication inhibited the manifestation of GLUT4 – the glucose transporter isoform 4, which is transported to the plasma membrane via the intracellular vesicles to a point where it is ready to imbibe glucose. This occurs through the stimulation of glucose uptake in cells through insulin. This linear movement of GLUT4 is disrupted by Fenbendazole thereby reducing insulin-stimulated sugar uptake.
Furthermore, because fenbendazole works in the same way as colchicine (working together with a site on tubulin) still, remains very different from other Vinica alkaloids, it does not struggle with these alkaloids or other chemotherapies. Rather, it functions the same way as other benzimidazole compositions. Fenbendazole improves the anti-cancer effectiveness of other cancer treatments like radiotherapy, surgery, berberine, dichloroacetate (DCA), etc.
It is worth mentioning that a recent scientific publication posits that fenbendazole (and related drugs) possess the potential to reactivate genome p53. In this regard, it functions as a tumor suppressant, p53 which is termed Guardian of the Genome. It should be noted that this suppression ability can be impeded in some cancers.
In addition, the Nature publication went ahead to mention that a fenbendazole and DCA combination is a very effective one.
Is Fenbendazole safe for humans?
While the original application of fenbendazole was for the cure of parasitic worms in animals, one report published by the European Medicine Agency is quoted as positing that humans appear to effectively tolerate Fenben after oral exposure (oral dose (single) as much as 2,000 mg/person: 500 mg/person for 10 days straight).
Nevertheless, there is no critical study of long exposure available at the moment. This dearth of scientific documentation of long exposure is not unconnected to the type of medication considering that parasitic infections take between 1 and 2 weeks to be cleared.
That notwithstanding, numerous people have ingested fenbendazole as prophylaxis over the years in a bid to manage the recurrence of cancer. It is also effective against tumors. The treatment is known to be safe and side effects are rare, if they ever occur at all.
Concluding comments
We are grateful to have you here and for the time you’ve taken to read through this article. To learn more about Fenbendazole and gain some valuable insights, go on and take a look at other information available across our website.
https://www.fenbenlab.com/product/fenbendazole-powder/
